Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 30;11(3):764.
doi: 10.3390/jcm11030764.

Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study

Affiliations

Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study

Paulina Szczepanik-Kułak et al. J Clin Med. .

Abstract

Morphea, also known as localized scleroderma (LoS), is a chronic autoimmune disease of the connective tissue. The clinical picture of LoS distinguishes between active and inactive lesions. Sometimes the clinical findings are challenging to identify, and therefore, the need for additional methods is emphasized. Our study aimed to demonstrate the characteristic dermoscopic features in morphea skin lesions, focusing on demonstrating features in active and inactive lesions. In our patients (n = 31) with histopathologically proven LoS, we performed clinical evaluation of lesions (n = 162): active/inactive and according to both disease activity (modified localized scleroderma severity index, mLoSSI) and damage (localized scleroderma skin damage index, LoSDI) parameters. In addition, we took into account compression locations to determine whether skin trauma, a known etiopathogenetic factor in LoS, affects the dermoscopic pattern of the lesions. We performed a dermoscopy of the lesions, categorizing the images according to the severity within the observed field. We showed that within the active lesions (clinically and with high mLoSSI), white clouds and linear branching vessels had the highest severity. These features decreased within the observed field in inactive lesions and with high LoSDI. Brownish structureless areas were most intense in inactive lesions with high LoSDI. Erythematous areas, linear branching vessels, dotted vessels, and crystalline structures were statistically significant for pressure locations. We have shown dermoscopy is a valuable tool to assess the activity or inactivity of lesions, which translates into appropriate therapeutic decisions and the possibility of monitoring the patient during and after therapy for possible relapse.

Keywords: dermoscopy; localized scleroderma; morphea.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Compression locations considered.
Figure 2
Figure 2
The orange box shows 4 dermoscopic images of active LoS lesions. The red asterisks mark the white clouds. Linear branching vessels are also seen scattered throughout the field. The blue box shows two dermoscopic images of active LoS lesions. Dotted vessels are visible, as well as widely scattered fine white clouds. The green frame shows a dermoscopic image of inactive lesions. The presence of reticulated brown areas is notable.

Similar articles

Cited by

References

    1. Krasowska D., Rudnicka L., Dańczak-Pazdrowska A., Chodorowska G., Woźniacka A., Lis-Święty A., Czuwara J., Maj J., Majewski S., Sysa-Jędrzejowska A., et al. Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Dermatol. Rev. 2019;106:333–353. doi: 10.5114/dr.2019.88252. - DOI
    1. Abbas L., Joseph A., Kunzler E., Jacobe H.T. Morphea: Progress to date and the road ahead. Ann. Transl. Med. 2021;9:437. doi: 10.21037/atm-20-6222. - DOI - PMC - PubMed
    1. Eckes B., Wang F., Moinzadeh P., Hunzelmann N., Krieg T. Pathophysiological Mechanisms in Sclerosing Skin Diseases. Front. Med. 2017;4:120. doi: 10.3389/fmed.2017.00120. - DOI - PMC - PubMed
    1. Errichetti E., Stinco G. Morphea. In: Micali G., Lacarrubba F., Stinco G., Argenziano G., Neri I., editors. Atlas of Pediatric Dermatoscopy. Springer; Cham, Switzerland: 2018. pp. 115–119. - DOI
    1. Knobler R., Moinzadeh P., Hunzelmann N., Kreuter A., Cozzio A., Mouthon L., Cutolo M., Rongioletti F., Denton C., Rudnicka L., et al. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes. J. Eur. Acad. Dermatol. Venereol. 2017;31:1401–1424. doi: 10.1111/jdv.14458. - DOI - PubMed

LinkOut - more resources